1. Introduction
===============

Heart failure is a leading cause of hospitalization and readmission and more Medicare dollars are spent on heart failure than any other medical condition.^\[[@R1]\]^ As reported in the Atherosclerosis Risk in Communities (ARIC) study, there are \>915,000 new cases of heart failure every year^\[[@R2]\]^ in United States alone. Up to 50% of patients with heart failure are readmitted within 6 months of discharge^\[[@R3]\]^ with 23.5% of 30 days readmission rate and costing 2.7 billion dollars to the health care system in USA alone (Agency for Healthcare Research and Quality \[AHRQ\] data-2013). We conducted a retrospective analysis of the impact of multidisciplinary rounds (MDR) on 30-day readmissions and length of stay in hospitalized patients with a diagnosis of congestive heart failure in a community teaching hospital in Baltimore.

Educating patients and families regarding the chronicity and challenges of managing heart failure, as well as strategies to manage heart failure such as weight monitoring, dietary and medication compliance, and close post discharge follow-ups have been shown to decrease the chance of readmissions.^\[[@R4]\]^ Unfortunately, these valuable measures are often underutilized.

Many hospitals and health systems have developed their own quality assessment teams based on CMS requirements to ensure that all heart failure patients are discharged with appropriate medications (Guideline Directed Medical Therapy \[GDMT\]) including beta-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB), diuretics and aldosterone antagonists based on AHA/ACC guidelines unless contraindicated.^\[[@R5],[@R6]\]^

2. Methods
==========

We conducted a retrospective review of heart failure hospital admission and readmission data to assess the efficacy of multidisciplinary rounds (MDR) on patients admitted with primary diagnosis of heart failure in reducing the 30-day all-cause readmissions and decreasing length of stay in a community teaching hospital. "Our study was granted exempt status by our institutional review board for analysis of deidentified data."

2.1. Study population
---------------------

We included all patients hospitalized with a primary diagnosis of heart failure to our community teaching hospital during the study period. Study patients were divided into 2 groups. The control group included patients admitted before the implementation of MDR, from June 2012 to May 2013. The MDR group included patients admitted after implementation of MDR, from June 2015 to May 2016. Patients were excluded from review if they were younger than 18 years of age, died during their hospitalization, were transferred to either hospice or another acute care facility, or were pregnant at the time of admission.

2.2. Study outcomes
-------------------

The primary endpoint of this study was 30-day all cause readmission rate and the secondary end point was length of stay.

2.3. Multidisciplinary team
---------------------------

Our MDR team consists of a cardiologist, case manager, pharmacist, social worker, and a nutritionist. The MDR team rounds on all patients hospitalized with a primary diagnosis of heart failure and communicates directly with the primary medical team. The MDR team reviews clinical status, medication and dietary compliance, medication optimization as per GDMT, socioeconomic issues that may affect management of heart failure, and post-discharge follow up care. Additionally, the team educates patients and families on diet, weight monitoring, and fluid restriction.

2.4. Statistical methods and analysis
-------------------------------------

Data were collected by reviewing patient paper charts and electronic medical records. Total number of patients in control group was 181 with a mean age of 70.8 years and the test or MDR group had 151 patients with a mean age of 69.8 years. Remaining patient characteristics are listed in Table [1](#T1){ref-type="table"}.
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We conducted chi-square test to compare categorical data and Student *t* test to compare continuous data. We considered a *P*-value of \<.05 to be statistically significant. We conducted all analyses in Microsoft Excel (2017).

3. Results
==========

All-cause 30-day readmission rates were significantly decreased (27.56% vs 17.22%; relative risk (RR) 0.62; *P* value .026) and mean length of stay decreased from 5.6 days versus 5.0 days after MDR.

Readmission rates were analyzed based on heart failure etiology, systolic function, and sex. In patients with ischemic cardiomyopathy (ICM), we observed a significant reduction in readmissions (33.61% vs 14.01%; RR 0.42; *P* value .007). In patients with non-ischemic cardiomyopathy (NICM), there was no significant difference in readmission rate after MDR implementation (16.12% vs 19.15%; RR 1.19; *P* value .676).

We also observed a significant decrease in readmission rates in heart failure patients with reduced ejection fraction (31.34% vs 16.05%; RR 0.51; *P* value .028), ischemic cardiomyopathy (33.61% vs 14.01%; RR 0.42; *P* value .007) and also in male patients (27.17% vs 10.56%, RR 0.39; *P* value .015) after implementation of MDR. On the contrary we didn't find any significant decrease in readmissions in heart failure patients with preserved ejection fraction (24.49% vs 18.57%; RR 0.76; *P* value .451), non-ischemic cardiomyopathy (16.12% vs 19.15%; RR 1.19; *P* value .676), and also in female patients (28.08% vs 22.35%; RR 0.80; *P* value .486) (Fig. [1](#F1){ref-type="fig"}).
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Systolic function affected readmission rates independent of HF etiology: In patients with HFREF (both ICM and NICM) readmission rates were significantly lower after MDR implementation (31.34% vs 16.05%; RR 0.51; *P* value .028). There was no statistically significant change in readmission rate observed in patients with HFPEF (24.49% vs 18.57%; RR 0.76; *P* value .451).

Female patients demonstrated no difference in readmission rate after MDR implementation (28.08% vs 22.35%; RR 0.80; *P* value .486). Male patients had a significant decrease in readmissions after MDR (27.17% vs 10.6%, RR 0.39; *P* value .015).

4. Discussion
=============

In our study patients with HFrEF (both ICM and NICM) readmission rates were significantly lower after MDR implementation but no statistical difference in patients with HFpEF.

Decreasing the frequency of readmissions in HF patients would not only markedly decrease the overall cost of medical care but would also improve clinical outcomes and quality of life.^\[[@R7]\]^ A substantial proportion of patients admitted with HF have significant treatment gaps.^\[[@R8]\]^ The purpose of a multidisciplinary rounds program is to minimize the impact of educational and socioeconomic barriers in management of HF. The goal is to affect lifestyle modification, dietary patterns, and medication compliance to optimize management of HF.

However, we did not observe improvement in readmission rates in patients with non-ischemic cardiomyopathy, in patients with preserved EF, and in female patients. While we did not evaluate the causes for these differences, it is not surprising that the MDR strategy was most successful when applied to patients with HFREF as these are the patients in whom GDMT has been most thoroughly evaluated and found to be successful. The lack of success with MDR implementation when applied to patients with NICM and specifically those with HFPEF, may be explained by the more heterogeneous nature of this patient population and by the relative paucity of medical therapies specifically targeted to HFPEF.

A possible explanation for the sex difference may be that a higher proportion of female patients had either HFPEF or NICM as compared with male patients.

We noted a significant increase in the percentage of women hospitalized for heart failure (56.29% vs 49.17%; *P* value .19) and also an increased number of patients with NICM (62.25% vs 34.8%; *P* value .01) in the study period compared with control period. This increased rate of admissions for HF in women and in patients with HFPEF at our hospital matches nationally observed trends.^\[[@R9]\]^ As this growth trend coincides with the groups of patients that appeared to derive less benefit from MDR implementation, we have identified an opportunity to improve our management of HF.

With the gradual increase in population of patients with HF and the advent of various expensive device therapies for patients with advanced HF, the cost burden expected to increase by 240% by the year 2030.^\[[@R10]\]^ By decreasing 30-day readmissions, length of stay and increasing compliance with medications, we can decrease the avoidable financial burden on the health care system and patients.^\[[@R11]\]^ Decreased readmissions is a marker for improvement in the clinical status and quality of life of patients. Clearly, challenges remain, particularly in managing patients with increasingly more common forms of HF, specifically HFPEF.

4.1. Clinical perspectives
--------------------------

Assigning a team which includes cardiologist, case manager, pharmacist, social worker, and nutritionist to participate in multidisciplinary rounds on regular basis on all hospitalized heart failure patients will overcome many of the educational, and socio-economic barriers in the management of HF that contribute to HF readmissions. Based on our study, other retrospective and case control studies from the literature and a meta-analysis,^\[[@R6],[@R12]\]^ it is possible to show significant decreases in 30 days and 6 months' readmissions in the centers with innovative and creative approaches.^\[[@R9],[@R10]\]^

4.2. Limitations
----------------

Our study was limited by the retrospective nature, small sample size, and it being a single-center study. Furthermore, we lacked the data to assess 30-day readmissions to other hospitals in our geographic area, therefore potentially underestimating the true readmission rate to other hospitals. Additionally, we were unable to segregate patients hospitalized with a new diagnosis of heart failure as compared with an established heart failure diagnosis. Socioeconomic status of the population and its impact was not evaluated in this study. Future prospective studies will be helpful in evaluating effectiveness of MDR in improvement of patient satisfaction, cost-effectiveness, and its impact on the community.

5. Conclusion
=============

There is a significant drop in 30 days readmissions and length of stay of HF patients in our hospital after the implementation of multidisciplinary rounds. This strategy will decrease the chances of readmission, improves quality of care, clinical outcomes, patient\'s quality of life, and decreases financial burden on health care system.
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